Haelixa’s patented DNA-based technology provides physical, on-product proof of origin and authenticity. The company commercialises unique DNA markers designed to withstand all processing and treatment of materials throughout the supply chain. By testing products for the DNA as they journey through the value chain, Haelixa validates whether the original marked materials are present. 

Traceability allows brands to verify their claims and provides the data to calculate their environmental and social impact. As regulatory scrutiny rises and risks around fraud and counterfeiting increase, Haelixa’s technology helps brands protect compliance, brand value, and consumer trust. The solution is already used across textiles, precious metals, and gemstone. 

Founded in 2016 as a spin-off from ETH Zurich, Haelixa has already achieved scaled commercial adoption, seven-figure revenues and multi-year agreements with leading fashion and textile brands. 

Haelixa has now raised €2 million in a pre-series A round led by existing backers Verve Ventures and Zurich Kantonalbank, with participation from the impact-focused investor 212 NexT Fund. This complements the catalytic funding awarded through the Temasek Trust Amplifier programme. This investment will accelerate international expansion, targeted team growth, expanded offerings, and closer collaboration with textile brands and supply-chain partners.

“This investment enables us to scale globally as expectations for traceability continue to rise. It also allows us to expand into anti-counterfeiting, adding a strong new layer of value for luxury brands,” said Patrick Strumpf, CEO of Haelixa, in a recent press release. 

(www.startupticker.ch)